| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |